PAREXEL INTERNATIONAL FRANCE, SYMPOSIUM SESSION
June 20, 2018
Wednesday, June 20, 9:30 am – 12:30 pm
Navigate Updated EU Guidelines on Risk Mitigation for FIH & Early Clinical Trials
Meet with PAREXEL and your Pharma colleagues in Paris on Wednesday June 20, 2018, to hear industry experts discuss Current Principles of Regulatory Evaluation for Early Phase Protocols in relation to the New EMA Guideline (which became effective on February 1, 2018).
The symposium session will be led by pre-clinical, regulatory, and early phase experts within PAREXEL and will provide you with data on today’s challenges and innovations within Early Clinical development.
You will also have an opportunity to pre-schedule one-on-one discussions with our PAREXEL senior experts after lunch.
This symposium is COMPLIMENTARY for members of the biopharmaceutical industry and will be limited to 25 guests so please register soon! Networking luncheon will follow the event.
Featured PAREXEL Speakers include:
Dr. Matthias Grossmann
Vice President, Principal Consultant
Clinical Pharmacology, M.D., Ph.D.
Principal Consultant, PAREXEL Consulting
Scientific Director, Quantitative Clinical Development